Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:34 PM
Ignite Modification Date:
2025-12-24 @ 9:34 PM
NCT ID:
NCT04374032
Eligibility Criteria:
Inclusion Criteria:
* Patients with laboratory-confirmed (PCR) COVID-19 infection
* Patients with moderate to severe COVID-19 infection
* Hospitalized patients on clinical centers and cantonal hospitals
* Patients with radiology-confirmed pneumonia within the clinical condition of COVID-19 infection including pulmonary opacity
* Patients with a clinical indication for pneumonia: increased body temperature (defined as a value above ≥ 36.6⁰C axillary route, ≥ 37.2°C oral route or ≥ 37.8 °C rectal route), and/or dyspnea, and/or cough, and/or SpO2 \<96%
* Patients aged above 18, both genders
* Patients able and willing to understand the study, adhere to all study procedures and sign a written Informed Consent Form (ICF) prior to entering the study or with the assistance of the witness
Exclusion Criteria:
* Patients not COVID-19 positive
* Patients with mild COVID-19 infection
* Patients who are study subjects in another clinical study for another investigational agent for COVID-19
* Patients with malignant hypertension
* Patients with malignant disease and who are treated for malignant diseases in the last 5 years
* Patients with severe liver and kidney insufficiency
* Patients who are receiving therapy with an immunomodulatory or immunosuppressive agent
* Patients aged below 18, female patients who are pregnant or breastfeeding
* Known allergy to study drug or any component thereof
* Use of haloperidol, dopamine antagonists, or nonsteroidal anti-inflammatory drugs, except paracetamol.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04374032
Study Brief:
Protocol Section:
NCT04374032